1133 results
-
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 May 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 16/05/2022 to 19/05/2022, Last updated: 12/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2022 to 22/04/2022, Last updated: 12/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 12/08/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 14-16 June 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 14/06/2022 to 16/06/2022, Last updated: 22/07/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 12-14 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 12/07/2022 to 14/07/2022, Last updated: 12/07/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 20/06/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 11-13 April 2022
European Medicines Agency, Amsterdam, the Netherlands, from 11/04/2022 to 13/04/2022, Last updated: 16/06/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/01/2022 to 27/01/2022, Last updated: 16/03/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 18-20 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 18/01/2022 to 20/01/2022, Last updated: 27/01/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 8-11 November 2021
Online, from 08/11/2021 to 11/11/2021, Last updated: 20/01/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 11/10/2021 to 14/10/2021, Last updated: 20/01/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 5-7 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/10/2021 to 07/10/2021, Last updated: 14/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 17/05/2021 to 20/05/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 21/06/2021 to 24/06/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2021 to 22/04/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 March 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/03/2021 to 25/03/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/02/2021 to 25/02/2021, Last updated: 07/12/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 7-9 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/12/2021 to 09/12/2021, Last updated: 06/12/2021 -
List item
News: COVID-19: EMA recommends authorisation of two monoclonal antibody medicines
CHMP, Last updated: 12/11/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 15-17 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 15/06/2021 to 17/06/2021, Last updated: 24/06/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 13-15 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 13/04/2021 to 15/04/2021, Last updated: 11/06/2021 -
List item
News: EMA reminds physicians to use Tecentriq with nab-paclitaxel for treating breast cancer
CHMP, Last updated: 21/05/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 10-12 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 10/05/2021 to 12/05/2021, Last updated: 10/05/2021